-+ 0.00%
-+ 0.00%
-+ 0.00%

United Therapeutics Chairperson and CEO Martine Rothblatt disposes of 7,500 common shares for $3.93 million

PUBT·08/28/2026 20:31:34
Listen to the news
United Therapeutics Chairperson and CEO Martine Rothblatt disposes of 7,500 common shares for $3.93 million
  • United Therapeutics Chairperson and CEO Martine A. Rothblatt exercised stock options for 9,500 shares at USD 135.42.
  • The trust then sold 8,500 shares at weighted average prices around USD 511.58 to USD 531.12.
  • Trust holdings fell to 324,443 shares following the transactions on Aug. 27.
  • The trust holds 46,910 stock options after the exercise.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. United Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001106578-26-000130), on August 28, 2026, and is solely responsible for the information contained therein.